ID   PECR_HUMAN              Reviewed;         303 AA.
AC   Q9BY49; B2RE42; Q53TC4; Q6IAK9; Q9NRD4; Q9NY60; Q9P1A4;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   29-MAR-2005, sequence version 2.
DT   07-APR-2021, entry version 170.
DE   RecName: Full=Peroxisomal trans-2-enoyl-CoA reductase {ECO:0000305};
DE            Short=TERP;
DE            EC=1.3.1.38 {ECO:0000269|PubMed:10811639};
DE   AltName: Full=2,4-dienoyl-CoA reductase-related protein;
DE            Short=DCR-RP;
DE   AltName: Full=HPDHase;
DE   AltName: Full=Short chain dehydrogenase/reductase family 29C member 1;
DE   AltName: Full=pVI-ARL;
GN   Name=PECR {ECO:0000312|HGNC:HGNC:18281}; Synonyms=SDR29C1;
GN   ORFNames=PRO1004;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ENZYME ACTIVITY, CATALYTIC
RP   ACTIVITY, AND FUNCTION.
RX   PubMed=10811639; DOI=10.1074/jbc.m001168200;
RA   Das A.K., Uhler M.D., Hajra A.K.;
RT   "Molecular cloning and expression of mammalian peroxisomal trans-2-enoyl-
RT   coenzyme A reductase cDNAs.";
RL   J. Biol. Chem. 275:24333-24340(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, INTERACTION
RP   WITH PEX5, AND MUTAGENESIS OF LEU-303.
RX   PubMed=11669066; DOI=10.2174/1386207013330832;
RA   Amery L., Mannaerts G.P., Subramani S., Van Veldhoven P.P., Fransen M.;
RT   "Identification of a novel human peroxisomal 2,4-dienoyl-CoA reductase
RT   related protein using the M13 phage protein VI phage display technology.";
RL   Comb. Chem. High Throughput Screen. 4:545-552(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Li Y., Wu T., Xu S., Ren S., Chen Z., Han Z.;
RT   "A novel gene expressed in human liver non-tumor tissues.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Fetal liver;
RA   Zhang C., Yu Y., Zhang S., Wei H., Zhang Y., Zhou G., Bi J., Liu M., He F.;
RT   "Functional prediction of the coding sequences of 79 new genes deduced by
RT   analysis of cDNA clones from human fetal liver.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INDUCTION.
RX   PubMed=11937624; DOI=10.1093/nar/30.8.1713;
RA   Braastad C.D., Leguia M., Hendrickson E.A.;
RT   "Ku86 autoantigen related protein-1 transcription initiates from a CpG
RT   island and is induced by p53 through a nearby p53 response element.";
RL   Nucleic Acids Res. 30:1713-1724(2002).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-49 AND TYR-179, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) IN COMPLEX WITH ADENINE AND
RP   PHOSPHATE.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of peroxisomal trans 2-enoyl CoA reductase (PECRA).";
RL   Submitted (MAY-2005) to the PDB data bank.
CC   -!- FUNCTION: Participates in chain elongation of fatty acids. Catalyzes
CC       the reduction of trans-2-enoyl-CoAs of varying chain lengths from 6:1
CC       to 16:1, having maximum activity with 10:1 CoA. Has no 2,4-dienoyl-CoA
CC       reductase activity. {ECO:0000269|PubMed:10811639}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a (2E)-enoyl-CoA + H(+) + NADPH = a 2,3-saturated acyl-CoA +
CC         NADP(+); Xref=Rhea:RHEA:33763, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:58856, ChEBI:CHEBI:65111; EC=1.3.1.38;
CC         Evidence={ECO:0000269|PubMed:10811639};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33764;
CC         Evidence={ECO:0000305|PubMed:10811639};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-decenoyl-CoA + H(+) + NADPH = decanoyl-CoA + NADP(+);
CC         Xref=Rhea:RHEA:44960, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:61406, ChEBI:CHEBI:61430;
CC         Evidence={ECO:0000269|PubMed:10811639};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44961;
CC         Evidence={ECO:0000305|PubMed:10811639};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-hexenoyl-CoA + H(+) + NADPH = hexanoyl-CoA + NADP(+);
CC         Xref=Rhea:RHEA:44956, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783,
CC         ChEBI:CHEBI:58349, ChEBI:CHEBI:62077, ChEBI:CHEBI:62620;
CC         Evidence={ECO:0000250|UniProtKB:Q9JIF5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44957;
CC         Evidence={ECO:0000250|UniProtKB:Q9JIF5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-octenoyl-CoA + H(+) + NADPH = NADP(+) + octanoyl-CoA;
CC         Xref=Rhea:RHEA:44952, ChEBI:CHEBI:15378, ChEBI:CHEBI:57386,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:62242;
CC         Evidence={ECO:0000250|UniProtKB:Q9JIF5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44953;
CC         Evidence={ECO:0000250|UniProtKB:Q9JIF5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-dodecenoyl-CoA + H(+) + NADPH = dodecanoyl-CoA + NADP(+);
CC         Xref=Rhea:RHEA:44964, ChEBI:CHEBI:15378, ChEBI:CHEBI:57330,
CC         ChEBI:CHEBI:57375, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349;
CC         Evidence={ECO:0000250|UniProtKB:Q9JIF5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44965;
CC         Evidence={ECO:0000250|UniProtKB:Q9JIF5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-tetradecenoyl-CoA + H(+) + NADPH = NADP(+) +
CC         tetradecanoyl-CoA; Xref=Rhea:RHEA:44968, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57385, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349,
CC         ChEBI:CHEBI:61405; Evidence={ECO:0000250|UniProtKB:Q9JIF5};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44969;
CC         Evidence={ECO:0000250|UniProtKB:Q9JIF5};
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC       {ECO:0000269|PubMed:10811639}.
CC   -!- SUBUNIT: Interacts with PEX5, probably required to target it into
CC       peroxisomes. {ECO:0000269|PubMed:11669066, ECO:0000269|Ref.11}.
CC   -!- SUBCELLULAR LOCATION: Peroxisome {ECO:0000269|PubMed:11669066}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BY49-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BY49-2; Sequence=VSP_013260;
CC   -!- INDUCTION: Not induced by IR. {ECO:0000269|PubMed:11937624}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF232009; AAF69798.1; -; mRNA.
DR   EMBL; AJ250303; CAB89810.1; -; mRNA.
DR   EMBL; AF212234; AAK14920.1; -; mRNA.
DR   EMBL; AF119841; AAF69595.1; -; mRNA.
DR   EMBL; CR457145; CAG33426.1; -; mRNA.
DR   EMBL; AK315795; BAG38139.1; -; mRNA.
DR   EMBL; AC010686; AAY14657.1; -; Genomic_DNA.
DR   EMBL; BC002529; AAH02529.1; -; mRNA.
DR   CCDS; CCDS33375.1; -. [Q9BY49-1]
DR   RefSeq; NP_060911.2; NM_018441.5. [Q9BY49-1]
DR   RefSeq; XP_011509780.1; XM_011511478.2.
DR   PDB; 1YXM; X-ray; 1.90 A; A/B/C/D=1-303.
DR   PDBsum; 1YXM; -.
DR   SMR; Q9BY49; -.
DR   BioGRID; 120932; 14.
DR   IntAct; Q9BY49; 10.
DR   STRING; 9606.ENSP00000265322; -.
DR   DrugBank; DB00173; Adenine.
DR   SwissLipids; SLP:000001094; -.
DR   iPTMnet; Q9BY49; -.
DR   PhosphoSitePlus; Q9BY49; -.
DR   BioMuta; PECR; -.
DR   DMDM; 62287123; -.
DR   EPD; Q9BY49; -.
DR   jPOST; Q9BY49; -.
DR   MassIVE; Q9BY49; -.
DR   MaxQB; Q9BY49; -.
DR   PaxDb; Q9BY49; -.
DR   PeptideAtlas; Q9BY49; -.
DR   PRIDE; Q9BY49; -.
DR   ProteomicsDB; 79584; -. [Q9BY49-1]
DR   ProteomicsDB; 79585; -. [Q9BY49-2]
DR   Antibodypedia; 20074; 184 antibodies.
DR   DNASU; 55825; -.
DR   Ensembl; ENST00000265322; ENSP00000265322; ENSG00000115425. [Q9BY49-1]
DR   GeneID; 55825; -.
DR   KEGG; hsa:55825; -.
DR   UCSC; uc002vft.4; human. [Q9BY49-1]
DR   CTD; 55825; -.
DR   DisGeNET; 55825; -.
DR   GeneCards; PECR; -.
DR   HGNC; HGNC:18281; PECR.
DR   HPA; ENSG00000115425; Tissue enhanced (liver).
DR   MIM; 605843; gene.
DR   neXtProt; NX_Q9BY49; -.
DR   OpenTargets; ENSG00000115425; -.
DR   PharmGKB; PA134967510; -.
DR   VEuPathDB; HostDB:ENSG00000115425.13; -.
DR   eggNOG; KOG0725; Eukaryota.
DR   GeneTree; ENSGT00940000156882; -.
DR   HOGENOM; CLU_010194_1_2_1; -.
DR   InParanoid; Q9BY49; -.
DR   OMA; NAWHYIP; -.
DR   OrthoDB; 1194344at2759; -.
DR   PhylomeDB; Q9BY49; -.
DR   TreeFam; TF315256; -.
DR   BioCyc; MetaCyc:HS03889-MONOMER; -.
DR   BRENDA; 1.3.1.38; 2681.
DR   PathwayCommons; Q9BY49; -.
DR   Reactome; R-HSA-389599; Alpha-oxidation of phytanate.
DR   Reactome; R-HSA-9033241; Peroxisomal protein import.
DR   UniPathway; UPA00094; -.
DR   BioGRID-ORCS; 55825; 6 hits in 991 CRISPR screens.
DR   ChiTaRS; PECR; human.
DR   EvolutionaryTrace; Q9BY49; -.
DR   GeneWiki; PECR; -.
DR   GenomeRNAi; 55825; -.
DR   Pharos; Q9BY49; Tbio.
DR   PRO; PR:Q9BY49; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q9BY49; protein.
DR   Bgee; ENSG00000115425; Expressed in liver and 230 other tissues.
DR   ExpressionAtlas; Q9BY49; baseline and differential.
DR   Genevisible; Q9BY49; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005778; C:peroxisomal membrane; ISS:UniProtKB.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0019166; F:trans-2-enoyl-CoA reductase (NADPH) activity; IDA:UniProtKB.
DR   GO; GO:0001561; P:fatty acid alpha-oxidation; TAS:Reactome.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0033306; P:phytol metabolic process; IDA:UniProtKB.
DR   GO; GO:0008104; P:protein localization; TAS:Reactome.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR002347; SDR_fam.
DR   PRINTS; PR00081; GDHRDH.
DR   SUPFAM; SSF51735; SSF51735; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Fatty acid biosynthesis;
KW   Fatty acid metabolism; Lipid biosynthesis; Lipid metabolism; NADP;
KW   Oxidoreductase; Peroxisome; Phosphoprotein; Reference proteome.
FT   CHAIN           1..303
FT                   /note="Peroxisomal trans-2-enoyl-CoA reductase"
FT                   /id="PRO_0000054740"
FT   NP_BIND         23..47
FT                   /note="NADP"
FT                   /evidence="ECO:0000250"
FT   MOTIF           301..303
FT                   /note="Microbody targeting signal"
FT   ACT_SITE        179
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         32
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99MZ7"
FT   MOD_RES         49
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         179
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   VAR_SEQ         1..146
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.4, ECO:0000303|Ref.5"
FT                   /id="VSP_013260"
FT   VARIANT         149
FT                   /note="E -> K (in dbSNP:rs1429148)"
FT                   /id="VAR_021535"
FT   VARIANT         297
FT                   /note="F -> L (in dbSNP:rs9288513)"
FT                   /id="VAR_021536"
FT   MUTAGEN         303
FT                   /note="Missing: Abolishes localization to peroxisomes."
FT                   /evidence="ECO:0000269|PubMed:11669066"
FT   CONFLICT        22
FT                   /note="I -> F (in Ref. 2; CAB89810)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        129
FT                   /note="E -> R (in Ref. 2; CAB89810)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        135
FT                   /note="T -> S (in Ref. 2; CAB89810)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        248
FT                   /note="S -> P (in Ref. 5; CAG33426)"
FT                   /evidence="ECO:0000305"
FT   TURN            13..18
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   STRAND          20..24
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   TURN            25..27
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           29..40
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   STRAND          44..50
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           52..64
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   STRAND          74..78
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           84..98
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   STRAND          103..106
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           116..118
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           121..131
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           133..145
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           147..150
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   STRAND          152..157
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           169..188
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           190..192
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   STRAND          194..201
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           208..210
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           214..221
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           224..227
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           237..247
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           249..251
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   STRAND          258..262
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           265..267
FT                   /evidence="ECO:0007744|PDB:1YXM"
FT   HELIX           288..302
FT                   /evidence="ECO:0007744|PDB:1YXM"
SQ   SEQUENCE   303 AA;  32544 MW;  BCCE6AB89F58382C CRC64;
     MASWAKGRSY LAPGLLQGQV AIVTGGATGI GKAIVKELLE LGSNVVIASR KLERLKSAAD
     ELQANLPPTK QARVIPIQCN IRNEEEVNNL VKSTLDTFGK INFLVNNGGG QFLSPAEHIS
     SKGWHAVLET NLTGTFYMCK AVYSSWMKEH GGSIVNIIVP TKAGFPLAVH SGAARAGVYN
     LTKSLALEWA CSGIRINCVA PGVIYSQTAV ENYGSWGQSF FEGSFQKIPA KRIGVPEEVS
     SVVCFLLSPA ASFITGQSVD VDGGRSLYTH SYEVPDHDNW PKGAGDLSVV KKMKETFKEK
     AKL
//
